Recherche
-
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
(European Journal of Epidemiology. pp. 1-11, 2022-09-21)Article de revue -
Use of cardiovascular and antidiabetic drugs during COVID19 epidemic in France
(Fundamental & Clinical Pharmacology. vol. 36, n° S1, pp. 94-95, 2022-06)Article de revue -
Risk of first ischemic stroke and use of antidopaminergic antiemetics: A nationwide case-time-control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 22-23, 2022-06)Article de revue -
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
(BMJ. vol. 376, 2022-03-23)Article de revueLibre accès -
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
(Clinical Pharmacology and Therapeutics. vol. 103, n° 6, pp. 1038-1046, 2018-06)Article de revue -
Chronic polypharmacy at all age: a population-based drug utilization study
(Fundamental and Clinical Pharmacology. vol. 36, n° 2, pp. 405-413, 2022-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Fundamental and Clinical Pharmacology. vol. 36, pp. 111-111, 2022-06)Article de revue -
Real-Life Benefits of Statins for Cardiovascular Prevention in Elderly Subjects: A Population-Based Cohort Study
(The American Journal of Medicine. vol. 132, n° 6, pp. 740-748 e7, 2019)Article de revue -
The Reply : Impact of Average Daily and Cumulative Dose of Statins on Mortality Risk Among Healthy Elderly
(The American Journal of Medicine. vol. 132, n° 7, pp. e622, 2019)Article de revue -
Evaluation of Covid-19 vaccines: Pharmacoepidemiological aspects
(Thérapie. vol. 76, n° 4, pp. 305-309, 2021-05-07)Article de revue